Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies - Additional Information (Details)

v3.23.3
Commitments and Contingencies - Additional Information (Details) - USD ($)
$ in Thousands
1 Months Ended
Jun. 18, 2020
Aug. 26, 2019
Aug. 05, 2019
Jun. 30, 2017
Sep. 30, 2023
Purchase Commitment          
Supply Commitment [Line Items]          
Purchase commitment non cancelable and cancelable         $ 64
HA FVIII TCR Agreement [Member]          
Supply Commitment [Line Items]          
Royalties     $ 50    
HA ODN Agreement [member]          
Supply Commitment [Line Items]          
Royalties $ 60        
BML Agreement [Member]          
Supply Commitment [Line Items]          
Royalties   $ 11      
Cornell University | Neuromuscular Blocking Agents License Agreement          
Supply Commitment [Line Items]          
Amount of royalty payments due or payable         $ 0
U.S | Cornell University | Neuromuscular Blocking Agents License Agreement          
Supply Commitment [Line Items]          
Regulatory approval and commercialization milestones       $ 5,000  
European | Cornell University | Neuromuscular Blocking Agents License Agreement          
Supply Commitment [Line Items]          
Regulatory approval and commercialization milestones       3,000  
Minimum | Cornell University | Neuromuscular Blocking Agents License Agreement          
Supply Commitment [Line Items]          
Cost Maintenance       70  
Maximum | Cornell University | Neuromuscular Blocking Agents License Agreement          
Supply Commitment [Line Items]          
Cost Maintenance       $ 125